Young children may gain weight early due to their genetics, and this does not mean they face a lifelong risk of obesity, ...

In every single state, researchers expect at least 35% of adults to have a body mass index of 30 or higher, the threshold ...

A public health expert explains how GLP-1 drugs have changed the way healthcare providers understand and treat obesity.

The United Kingdom and Brazil have issued warnings about a possible link between GLP-1 weight-loss drugs and pancreatic inflammation, but the connection is murky.

After an FDA rejection of its spinocerebellar ataxia (SCA) therapy, Biohaven was forced to rethink its strategy—cutting R&D spend by 60% and channeling the spirit of a scrappy startup again as it ...

A global study shows obesity heightens the risk of severe infections and related deaths across multiple disease types and ...

Just over one in 10 deaths from a wide range of infectious diseases can be attributed to obesity worldwide, finds a major new ...

Clinicians warn that GLP-1 treatment often ends within a year and can lead to rapid weight regain; experts urge personalized nutrition, behavioral care, and continued research.

Research shows that metabolic surgery and GLP-1 medications are both effective therapies for treating obesity. Medications ...

The ad by Lilly India is opening the door to a weight loss conversation. It features links to research papers from the World ...

Excess weight is silently impacting intimacy, fertility, and emotional closeness in India. Dr. Prashanth Rao highlights how obesity disrupts hormone balance, reduces sexual desire, and can lead to ...